BioSpace2h
SpringWorks Wins FDA Nod for Neurofibromatosis Drug, Tees Up Challenge to AstraZeneca
The FDA on Tuesday signed off on SpringWorks Therapeutics’ mirdametinib—now to carry the brand name Gomekli—for the treatment ...
Pharmaceutical Technology4h
FDA approves Gomekli as first neurofibromatosis drug for adults
The US Food and Drug Administration (FDA) has approved SpringWorks Therapeutics’ Gomekli (mirdametinib) to treat ...
Cupid's Undie Run spreads the half-naked truth about Neurofibromatosis
Cupid's Undie Run sent dozens of half-naked runners through Saturday to raise awareness for a genetic disease.
fandomwire6d
What Is Neurofibromatosis? Condition Behind Adam Pearson’s Face
Adam Pearson used his neurofibromatosis struggles to succeed in acting and advocacy, inspiring others to accept differences ...
US FDA approves SpringWorks' genetic disorder drug
The U.S. Food and Drug Administration said on Tuesday it has approved SpringWorks Therapeutics' drug to treat a type of rare ...
FDA approves new genetic disorder drug
The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of non-cancerous tumors on ...
Medscape1d
FDA Approves Mirdametinib for Neurofibromatosis Type 1
The kinase inhibitor is now approved for adults and children aged ≥ 2 years with neurofibromatosis type 1 who have unresectable symptomatic plexiform neurofibromas.
UPDATE: SpringWorks Therapeutics Announces FDA Approval of GOMEKLIâ„¢ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...
Cupid’s Undie Run 2025: Cheeky charity event returns to Cleveland (photos)
Valentine's Day-themed fun run raises money for neurofibromatosis research while participants brave the cold in their ...
Cincinnatians brave the cold for Cupid’s Undie Run to raise awareness for NF
Cincinnatians brave the cold for Cupid's Undie Run at Queen City Radio, raising funds and awareness for Neurofibromatosis (NF ...
The Pharma Letter3h
FDA approves SpringWorks’ Gomekli
The US Food and Drug Administration approved Gomekli (mirdametinib), from SpringWorks Therapeutics, a kinase inhibitor, for adult and pediatric patients two years of age and older with ...